DNLI - Denali Therapeutics Inc.
IEX Last Trade
20.615
-0.015 -0.073%
Share volume: 13,676
Last Updated: Fri 27 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$20.63
-0.02
-0.07%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-27 | 2023-05-08 | 2023-08-08 | 2023-11-07 | 2024-02-28 | 2024-05-07 | 2024-08-01 | |
| Total revenue | 3.559 M | 10.283 M | 35.141 M | 294.123 M | 1.267 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 3.559 M | 10.283 M | 35.141 M | 294.123 M | 1.267 M | 0.000 | 0.000 | 0.000 | |
| 188.93% | 241.74% | 736.98% | -99.57% | -100.00% | nan% | nan% | |||
| Operating expenses | 111.045 M | 115.627 M | 155.956 M | 123.640 M | 115.062 M | 132.572 M | 132.252 M | 116.593 M | |
| Selling general and admin | 23.259 M | 23.516 M | 27.140 M | 26.120 M | 25.325 M | 24.769 M | 25.236 M | 25.194 M | |
| Research and development | 87.786 M | 92.111 M | 128.816 M | 97.520 M | 89.737 M | 107.803 M | 107.016 M | 91.399 M | |
| Total expenses | 111.045 M | 115.627 M | 155.956 M | 123.640 M | 115.062 M | 132.572 M | 132.252 M | 116.593 M | |
| 4.13% | 34.88% | -20.72% | -6.94% | 15.22% | -0.24% | -11.84% | |||
| Operating income | -107.486 M | -105.344 M | -120.815 M | 170.483 M | -113.795 M | -132.572 M | -132.252 M | -116.593 M | |
| Ebit | -107.486 M | -105.344 M | -120.815 M | 170.483 M | -113.795 M | -132.572 M | -132.252 M | -116.593 M | |
| Pretax income | -103.299 M | -98.684 M | -109.781 M | 183.383 M | -99.353 M | -119.443 M | -101.802 M | -99.026 M | |
| -4.47% | 11.24% | -267.04% | -154.18% | 20.22% | -14.77% | -2.73% | |||
| Income tax | 0.000 | -6.000 K | 0.000 | 0.000 | 0.000 | 30.000 K | 0.000 | 0.000 | |
| Net income basic | -103.299 M | -98.678 M | -109.781 M | 183.383 M | -99.353 M | -119.473 M | -101.802 M | -99.026 M | |
| 4.47% | -11.25% | 267.04% | -154.18% | -20.25% | 14.79% | 2.73% | |||
| Net income | -103.299 M | -98.678 M | -109.781 M | 183.383 M | -99.353 M | -119.473 M | -101.802 M | -99.026 M | |
| 4.47% | -11.25% | 267.04% | -154.18% | -20.25% | 14.79% | 2.73% |